11 | less than a week out from launch! any predictions | Bent2Break | 07/25/2017 2:01:54 PM |
10 | nice moves +29% doesn't take much volume to get | Bent2Break | 07/11/2017 12:31:26 PM |
9 | HRRN Financials 07/16/2014 19:16:15 HE-5 | Emylers | 07/16/2014 8:16:10 PM |
8 | HRRN 0.0002 Stock Charts $HRRN 1 Month Chart | chartguy89 | 03/07/2014 7:08:50 PM |
7 | HRRN Stock Charts Last: UNCH Wednesday, February | chartguy89 | 02/26/2014 9:58:49 PM |
6 | MY PLAYS LAST 5-7+ DAYS...HRRN IS GOING INTO DAY | stockfalcon | 02/19/2013 6:46:10 AM |
5 | HRRN .0009 im telling you all we are going to | stockfalcon | 02/19/2013 6:45:32 AM |
4 | Many groups joining in on tuesday...alerted at | stockfalcon | 02/18/2013 6:27:37 PM |
3 | The reason why it moved from .0002 to .0009 so | stockfalcon | 02/18/2013 6:25:58 PM |
2 | Check the chart back in oct last year....took | stockfalcon | 02/18/2013 6:25:19 PM |
1 | HRRN .0009 Maxed AS/OS play...my favorite | stockfalcon | 02/18/2013 6:24:01 PM |
Recent Articles
- InspireMD Showcases Growth in First Quarter Financials
- Kymera Therapeutics Reveals Q1 2025 Financial Overview and Updates
- Insights on Boundless Bio's Recent Financial Performance
- Agios Pharmaceuticals Set to Showcase Innovations at Healthcare Conference
- Aclaris Therapeutics to Engage in Virtual Fireside Chat Series
- Rapid Micro Biosystems Shows Strong Growth in Q1 Financial Report
- Kymera Therapeutics Introduces Revolutionary IRF5 Program
- Diversified Energy's Latest Share Buyback Announcement
- Clearside Biomedical Showcases Innovations in Eye Therapy at ARVO
- uniQure Reports Strong Start to 2025 with Key Milestones
- Anika Therapeutics Q1 2025 Financial Performance Updates
- Akero Therapeutics Unveils Groundbreaking SYMMETRY Trial Results
- Details on Alpha Group International PLC and Recent Disclosures
- EIT Food Accelerator Network Welcomes New Innovative Startups
- Projected Growth of the Fatty Amines Market to $4.97 Billion
- Huawei Digital Power Showcases Advanced Power Solutions
- Revolutionizing Game Development with AI Technology Innovations
- Omega World Travel’s Gloria Bohan: Trailblazing Entrepreneurial Spirit
- SystImmune Showcases Promising Breast Cancer Treatment Advances
- Enbridge Chronicles Record Earnings and Strategic Growth Plans
- Starwood Property Trust Achieves Strong Financial Milestones
- Osteotec Partners with icotec for Enhanced Spine Therapy Solutions
- MediPharm Labs to Announce Q1 2025 Financial Results Soon
- Construction Partners Reports Strong Q2 2025 Financial Results
- Calumet Energy's Exciting First Quarter Financial Performance
- EIT Food Accelerator Network Welcomes 2025 Innovative Startups
- OXB Showcases Innovations at 28th Annual ASGCT Meeting
- ANI Pharmaceuticals Achieves Record Revenues in Q1 2025
- i-80 Gold Secures $135 Million in Innovative Funding Strategy
- EchoStar Reports Strong Financial Growth for Q1 2025
- April's Health Innovation Highlights and Major Updates
- Brookdale Senior Living's Upcoming Key Healthcare Conference
- Target Hospitality Sets Stage for Q1 2025 Financial Release
- Protalix BioTherapeutics Shares Strategic Details of Q1 2025
- TELUS Corporation Declares Cash Dividend for Shareholders
- Castellum, Inc. Achieves Milestone with Q1 Revenue Growth
- Embecta Corp. Announces Solid Fiscal 2025 Q2 Performance
- Hyperscale Data's Bitnile.com Unveils Nile Coin on Solana Blockchain
- Outbrain Q1 2025 Results: Growth and Strategic Partnerships
- Hesai Group Announces 2025 Financial Results Conference Call
- Exciting Updates: April's Most Interesting Consumer News
- Oryx Stainless Launches Major Facility in Southeast Asia for Green Steel
- TXNM Energy Achieves Strong Performance in Recent Quarter
- Highlights from April: Finance News Worth Noting
- Fluence Energy Investors Urged to Act Before Class Action Deadline
- Highlights of the Latest Innovations in Technology Announcements
- Bitget and SWEAT Partner to Empower Users in a New Era
- Gyre Therapeutics Shares Insight on Q1 2025 Performance
- Gravity Co., Ltd. Announces Strong Q1 2025 Financial Results
- Akero Therapeutics Shares Impressive Phase 2b SYMMETRY Results